This document is an excerpt from the EUR-Lex website
Document 32010R1238
Regulation (EU) No 1238/2010 of the European Parliament and of the Council of 15 December 2010 amending Annex I to Council Regulation (EEC) No 2658/87 as regards the provision of duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals
Verordening (EU) nr. 1238/2010 van het Europees Parlement en de Raad van 15 december 2010 tot wijziging van bijlage I bij Verordening (EEG) nr. 2658/87 van de Raad betreffende vrijstelling van rechten voor bepaalde farmaceutische werkzame bestanddelen met een „internationale generieke benaming” ( „international non-proprietary name” , INN) van de Wereldgezondheidsorganisatie en voor bepaalde producten die gebruikt worden voor de vervaardiging van farmaceutische eindproducten
Verordening (EU) nr. 1238/2010 van het Europees Parlement en de Raad van 15 december 2010 tot wijziging van bijlage I bij Verordening (EEG) nr. 2658/87 van de Raad betreffende vrijstelling van rechten voor bepaalde farmaceutische werkzame bestanddelen met een „internationale generieke benaming” ( „international non-proprietary name” , INN) van de Wereldgezondheidsorganisatie en voor bepaalde producten die gebruikt worden voor de vervaardiging van farmaceutische eindproducten
PB L 348 van 31.12.2010, p. 36–73
(BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
- Date of document:
- 15/12/2010
- Date of effect:
- 01/01/2011; in werking datum publicatie +1 zie art 2
- Date of effect:
- 01/01/2011; Toepassing zie art 2
- Date of end of validity:
- No end date
- Author:
- Europees Parlement, Raad van de Europese Unie
- Form:
- Verordening
- Procedure number:
- Link
- European Parliament - Legislative observatory
- Treaty:
- Verdrag betreffende de werking van de Europese Unie
- Legal basis:
- Proposal:
- Link
- Link
- Link
- Link
- Link
- Select all documents mentioning this document No data available in the table
- Modifies:
-
Relation Act Comment Subdivision concerned From To Modifies 31987R2658 wijziging bijlage I 01/01/2011 - Link
- EUROVOC descriptor:
- Subject matter:
- Directory code:
-
- 02.20.10.10 Douane-unie en vrij verkeer van goederen / Basisinstrumenten van de douanepolitiek / Douanetarieven / Gemeenschappelijk douanetarief
- 02.20.10.30 Douane-unie en vrij verkeer van goederen / Basisinstrumenten van de douanepolitiek / Douanetarieven / Op overeenkomsten berustende tarieven (Taric)
|
31.12.2010 |
NL |
Publicatieblad van de Europese Unie |
L 348/36 |
VERORDENING (EU) Nr. 1238/2010 VAN HET EUROPEES PARLEMENT EN DE RAAD
van 15 december 2010
tot wijziging van bijlage I bij Verordening (EEG) nr. 2658/87 van de Raad betreffende vrijstelling van rechten voor bepaalde farmaceutische werkzame bestanddelen met een „internationale generieke benaming” („international non-proprietary name”, INN) van de Wereldgezondheidsorganisatie en voor bepaalde producten die gebruikt worden voor de vervaardiging van farmaceutische eindproducten
HET EUROPEES PARLEMENT EN DE RAAD VAN DE EUROPESE UNIE,
Gezien het Verdrag betreffende de werking van de Europese Unie, en met name op artikel 207,
Gezien het voorstel van de Europese Commissie,
Na toezending van het ontwerp van wetgevingshandeling aan de nationale parlementen,
Handelend volgens de gewone wetgevingsprocedure (1),
Overwegende hetgeen volgt:
|
(1) |
Tijdens de onderhandelingen in het kader van de Uruguay-ronde zijn de Gemeenschap en een aantal landen overeengekomen dat farmaceutische producten die onder hoofdstuk 30 en onder de posten 2936, 2937, 2939 en 2941 van het geharmoniseerd systeem (GS) vallen, alsmede bepaalde farmaceutisch werkzame stoffen met een „internationale generieke benaming” (INN) van de Wereldgezondheidsorganisatie, bepaalde zouten, esters en hydraten van deze stoffen en bepaalde farmaceutische tussenproducten voor de bereiding en vervaardiging van farmaceutische eindproducten, van rechten moeten worden vrijgesteld. |
|
(2) |
De resultaten van de besprekingen, zoals neergelegd in de Record of Discussions, zijn opgenomen in de tarieflijsten van de deelnemers die als bijlage bij het Protocol van Marrakech bij de General Agreement on Tariffs and Trade (GATT) van 1994 zijn gevoegd. |
|
(3) |
De deelnemers besloten dat de vertegenwoordigers van de leden van de Wereldhandelsorganisatie (WTO) die partij zijn bij de Record of Discussions normaal gesproken ten minste om de drie jaar onder auspiciën van de Raad voor de handel in goederen van de WTO zouden samenkomen om de lijst van voor vrijstelling van rechten in aanmerking komende producten te onderzoeken teneinde bij consensus nog andere farmaceutische producten daarin op te nemen. |
|
(4) |
Inmiddels hebben drie van die herzieningsonderzoeken plaatsgevonden, met als gevolg dat nog een aantal INN's en voor de bereiding en vervaardiging van farmaceutische eindproducten gebruikte farmaceutische tussenproducten van rechten zijn vrijgesteld, dat sommige van die tussenproducten naar de lijst van INN's zijn verplaatst en dat de lijst van voor- en achtervoegsels voor zouten, esters en hydraten van INN's is uitgebreid. |
|
(5) |
Een vierde herzieningsonderzoek werd noodzakelijk geacht en hiermee is in 2009 begonnen. Dit onderzoek leidde tot de conclusie dat nog een aantal INN's en voor de bereiding en vervaardiging van farmaceutische eindproducten gebruikte farmaceutische tussenproducten moeten worden vrijgesteld van rechten, dat sommige van deze al in de farmaceutische sectoriële regeling en haar wijzigingen opgenomen farmaceutische tussenproducten naar de lijst van INN's moeten worden verplaatst en dat de lijst van voor- en achtervoegsels voor zouten, esters en hydraten van INN's moet worden uitgebreid. |
|
(6) |
Bij Verordening (EEG) nr. 2658/87 van de Raad van 23 juli 1987 met betrekking tot de tarief- en statistieknomenclatuur en het gemeenschappelijk douanetarief (2) is de gecombineerde nomenclatuur (GN) ingesteld en zijn de conventionele rechten van het gemeenschappelijk douanetarief vastgesteld. |
|
(7) |
Verordening (EEG) nr. 2658/87 moet daarom dienovereenkomstig worden gewijzigd. |
|
(8) |
Om te waarborgen dat de in deze verordening vervatte maatregelen vanaf 1 januari 2011 van toepassing worden, moet zij op de dag na die van bekendmaking ervan in werking treden, |
HEBBEN DE VOLGENDE VERORDENING VASTGESTELD:
Artikel 1
Bijlagen 3, 4 en 6 bij afdeling II van het derde deel van bijlage I bij Verordening (EEG) nr. 2658/87 (Lijsten van farmaceutische stoffen die vrij van rechten kunnen worden ingevoerd) worden als volgt gewijzigd:
|
1) |
Met ingang van 1 januari 2011 verleent de Unie vrijstelling van rechten voor de in bijlage I opgenomen INN's. |
|
2) |
Met ingang van 1 januari 2011 wordt de lijst van voor- en achtervoegsels die in combinatie met de in de farmaceutische sectoriële regeling en haar wijzigingen opgenomen INN's de zouten, esters en hydraten van INN's aangeven die ook in aanmerking komen voor vrijstelling van rechten, mits zij onder dezelfde zescijferige GS-tariefonderverdeling vallen als de desbetreffende INN, gewijzigd overeenkomstig bijlage II. |
|
3) |
Met ingang van 1 januari 2011 verleent de Unie vrijstelling van rechten voor de in bijlage III opgenomen farmaceutische tussenproducten die worden gebruikt voor de bereiding en vervaardiging van farmaceutische eindproducten. |
|
4) |
Met ingang van 1 januari 2011 worden de in bijlage IV opgenomen farmaceutische tussenproducten geschrapt van de lijst van farmaceutische tussenproducten waarop geen rechten van toepassing zijn. |
Artikel 2
Deze verordening treedt in werking op de dag na die van bekendmaking ervan in het Publicatieblad van de Europese Unie.
Zij is van toepassing met ingang van 1 januari 2011.
Deze verordening is verbindend in al haar onderdelen en is rechtstreeks toepasselijk in elke lidstaat.
Gedaan te Straatsburg, 15 december 2010.
Voor het Europees Parlement
De voorzitter
J. BUZEK
Voor de Raad
De voorzitter
O. CHASTEL
(1) Standpunt van het Europees Parlement van 23 november 2010 (nog niet bekendgemaakt in het Publicatieblad) en besluit van de Raad van 10 december 2010.
(2) PB L 256 van 7.9.1987, blz. 1.
BIJLAGE I
Lijst van internationale generieke benamingen („international non-proprietary name”, INN) die moeten worden toegevoegd aan de lijst van producten waarop geen rechten van toepassing zijn in bijlage 3 bij bijlage I bij Verordening (EEG) nr. 2658/87
|
GN-code |
CAS-nummer |
Naam |
|
2842 90 80 |
119175-48-3 |
fermagaat |
|
2843 90 90 |
759457-82-4 |
padeliporfin |
|
2844 40 30 |
123748-56-1 |
jodofiltinezuur (
|
|
2904 10 00 |
21668-77-9 |
eprodisaat |
|
2906 19 00 |
199798-84-0 |
elocalcitol |
|
2909 30 90 |
24150-24-1 |
terameprocol |
|
2916 19 95 |
81485-25-8 |
peretinoïne |
|
2916 39 00 |
51543-40-9 |
tarenflurbil |
|
2918 19 98 |
174022-42-5 |
bevirimat |
|
2919 90 00 |
258516-89-1 |
fospropofol |
|
2920 90 85 |
163133-43-5 |
naproxcinod |
|
2921 19 99 |
3687-18-1 |
tramiprosaat |
|
2922 19 85 |
68392-35-8 |
afimoxifeen |
|
2922 19 85 |
753449-67-1 |
ronacaleret |
|
2922 29 00 |
433265-65-7 |
faxeladol |
|
2922 50 00 |
121524-08-1 |
amibegron |
|
2922 50 00 |
329773-35-5 |
cinaciguat |
|
2922 50 00 |
643094-49-9 |
fasobegron |
|
2923 10 00 |
856676-23-8 |
cholinefenofibraat |
|
2924 29 98 |
847353-30-4 |
arbaclofenplacarbil |
|
2924 29 98 |
194785-19-8 |
bedoradrine |
|
2924 29 98 |
194085-75-1 |
carisbamaat |
|
2924 29 98 |
254750-02-2 |
emricasan |
|
2924 29 98 |
355129-15-6 |
eprotirome |
|
2924 29 98 |
402567-16-2 |
firategrast |
|
2924 29 98 |
478296-72-9 |
gabapentinenacarbil |
|
2924 29 98 |
15866-90-7 |
incyclinide |
|
2924 29 98 |
202844-10-8 |
indantadol |
|
2924 29 98 |
96847-55-1 |
levomilnacipran |
|
2924 29 98 |
608137-32-2 |
lisdexamfetamine |
|
2924 29 98 |
652990-07-3 |
milveterol |
|
2924 29 98 |
181816-48-8 |
ombrabulin |
|
2924 29 98 |
289656-45-7 |
senicapoc |
|
2925 19 95 |
19171-19-8 |
pomalidomide |
|
2928 00 90 |
22033-87-0 |
olesoxim |
|
2928 00 90 |
2675-35-6 |
sivifeen |
|
2928 00 90 |
816458-31-8 |
tecovirimat |
|
2928 00 90 |
238750-77-1 |
tosedostat |
|
2928 00 90 |
149647-78-9 |
vorinostat |
|
2929 90 00 |
31645-39-3 |
palifosfamide |
|
2930 90 99 |
608141-41-9 |
apremilast |
|
2930 90 99 |
216167-92-9 |
camobucol |
|
2930 90 99 |
211513-37-0 |
dalcetrapib |
|
2930 90 99 |
69819-86-9 |
darinaparsin |
|
2930 90 99 |
488832-69-5 |
elesclomol |
|
2930 90 99 |
216167-95-2 |
elsibucol |
|
2930 90 99 |
168682-53-9 |
ezatiostat |
|
2930 90 99 |
58569-55-4 |
metenkefaline |
|
2930 90 99 |
887148-69-8 |
monepantel |
|
2930 90 99 |
603139-19-1 |
odanacatib |
|
2930 90 99 |
162520-00-5 |
salirasib |
|
2930 90 99 |
216167-82-7 |
succinobucol |
|
2930 90 99 |
125961-82-2 |
tipelukast |
|
2931 00 99 |
125973-56-0 |
amsilaroteen |
|
2932 19 00 |
253128-41-5 |
eribulin |
|
2932 19 00 |
186953-56-0 |
pafuramidine |
|
2932 29 85 |
195883-06-8 |
omtriptolide |
|
2932 99 00 |
664338-39-0 |
arterolaan |
|
2932 99 00 |
183133-96-2 |
cabazitaxel |
|
2932 99 00 |
401925-43-7 |
celivaron |
|
2932 99 00 |
461432-26-8 |
dapagliflozin |
|
2932 99 00 |
118457-15-1 |
dexnebivolol |
|
2932 99 00 |
156294-36-9 |
larotaxel |
|
2932 99 00 |
118457-16-2 |
levonebivolol |
|
2932 99 00 |
83461-56-7 |
mifamurtide |
|
2932 99 00 |
117570-53-3 |
vadimezan |
|
2933 19 90 |
496775-61-2 |
eltrombopag |
|
2933 19 90 |
206884-98-2 |
niraxostat |
|
2933 19 90 |
410528-02-8 |
palovaroteen |
|
2933 19 90 |
376592-42-6 |
totrombopag |
|
2933 29 90 |
183659-72-5 |
catramilast |
|
2933 29 90 |
944263-65-4 |
demiditraz |
|
2933 29 90 |
867153-61-5 |
dulanermin |
|
2933 29 90 |
320367-13-3 |
lixisenatide |
|
2933 29 90 |
698389-00-3 |
rolipoltide |
|
2933 29 90 |
697766-75-9 |
velafermin |
|
2933 39 99 |
147084-10-4 |
alcaftadine |
|
2933 39 99 |
54-96-6 |
amifampridine |
|
2933 39 99 |
249921-19-5 |
anamorelin |
|
2933 39 99 |
319460-85-0 |
axitinib |
|
2933 39 99 |
208110-64-9 |
befiradol |
|
2933 39 99 |
330942-05-7 |
betrixaban |
|
2933 39 99 |
201034-75-5 |
daporinad |
|
2933 39 99 |
209783-80-2 |
entinostat |
|
2933 39 99 |
412950-27-7 |
goxalapladib |
|
2933 39 99 |
218791-21-0 |
imisopasemmangaan |
|
2933 39 99 |
103129-82-4 |
levamlodipine |
|
2933 39 99 |
154357-42-3 |
levonadifloxacin |
|
2933 39 99 |
108147-54-2 |
migalastat |
|
2933 39 99 |
453562-69-1 |
motesanib |
|
2933 39 99 |
139145-27-0 |
parogrelil |
|
2933 39 99 |
459856-18-9 |
pexacerfont |
|
2933 39 99 |
706779-91-1 |
pimavanserin |
|
2933 39 99 |
362665-56-3 |
pitolisant |
|
2933 39 99 |
861151-12-4 |
rosonabant |
|
2933 39 99 |
701977-09-5 |
taranabant |
|
2933 39 99 |
189950-11-6 |
tropantiol |
|
2933 39 99 |
793655-64-8 |
vapitadine |
|
2933 39 99 |
139290-65-6 |
volinaserin |
|
2933 49 90 |
141388-76-3 |
besifloxacin |
|
2933 49 90 |
697761-98-1 |
elvitegravir |
|
2933 49 90 |
185055-67-8 |
ferrochine |
|
2933 49 90 |
445041-75-8 |
intichinatine |
|
2933 49 90 |
378746-64-6 |
nemonoxacin |
|
2933 49 90 |
245765-41-7 |
ozenoxacin |
|
2933 49 90 |
412950-08-4 |
rilapladib |
|
2933 49 90 |
871224-64-5 |
almorexant |
|
2933 49 90 |
863029-99-6 |
balamapimod |
|
2933 49 90 |
698387-09-6 |
neratinib |
|
2933 49 90 |
154652-83-2 |
tezampanel |
|
2933 49 90 |
128253-31-6 |
veliflapon |
|
2933 59 95 |
791828-58-5 |
aderbasib |
|
2933 59 95 |
840486-93-3 |
adipiplon |
|
2933 59 95 |
850649-61-5 |
alogliptin |
|
2933 59 95 |
859212-16-1 |
bafetinib |
|
2933 59 95 |
380843-75-4 |
bosutinib |
|
2933 59 95 |
839712-12-8 |
cariprazine |
|
2933 59 95 |
414910-27-3 |
casopitant |
|
2933 59 95 |
288383-20-0 |
cediranib |
|
2933 59 95 |
849550-05-6 |
cevipabulin |
|
2933 59 95 |
827318-97-8 |
danusertib |
|
2933 59 95 |
356057-34-6 |
darapladib |
|
2933 59 95 |
501000-36-8 |
dutacatib |
|
2933 59 95 |
247257-48-3 |
fimasartan |
|
2933 59 95 |
3432-99-3 |
folitixorin |
|
2933 59 95 |
668270-12-0 |
linagliptin |
|
2933 59 95 |
441798-33-0 |
macitentan |
|
2933 59 95 |
641571-10-0 |
nilotinib |
|
2933 59 95 |
763113-22-0 |
olaparib |
|
2933 59 95 |
686344-29-6 |
otenabant |
|
2933 59 95 |
625115-55-1 |
riociguat |
|
2933 59 95 |
486460-32-6 |
sitagliptin |
|
2933 59 95 |
425637-18-9 |
sotrastaurin |
|
2933 59 95 |
309913-83-5 |
talmapimod |
|
2933 59 95 |
113857-87-7 |
talotrexin |
|
2933 59 95 |
274693-27-5 |
ticagrelor |
|
2933 59 95 |
306296-47-9 |
vicriviroc |
|
2933 69 80 |
775351-65-0 |
imeglimin |
|
2933 79 00 |
461443-59-4 |
aplaviroc |
|
2933 79 00 |
189691-06-3 |
bremelanotide |
|
2933 79 00 |
813452-18-5 |
carmegliptin |
|
2933 79 00 |
405169-16-6 |
dovitinib |
|
2933 79 00 |
536748-46-6 |
eribaxaban |
|
2933 79 00 |
473289-62-2 |
ilepatril |
|
2933 79 00 |
180694-97-7 |
mimopezil |
|
2933 79 00 |
579475-18-6 |
orvepitant |
|
2933 79 00 |
449811-01-2 |
pamapimod |
|
2933 79 00 |
248282-01-1 |
paquinimod |
|
2933 79 00 |
380917-97-5 |
perampanel |
|
2933 79 00 |
552292-08-7 |
rolapitant |
|
2933 79 00 |
425386-60-3 |
semagacestat |
|
2933 79 00 |
515814-01-4 |
voclosporin |
|
2933 99 80 |
481629-87-2 |
aleplasinin |
|
2933 99 80 |
394730-60-0 |
boceprevir |
|
2933 99 80 |
649735-63-7 |
brivanibalaninaat |
|
2933 99 80 |
483369-58-0 |
denagliptin |
|
2933 99 80 |
284019-34-7 |
denibulin |
|
2933 99 80 |
481631-45-2 |
diaplasinin |
|
2933 99 80 |
272105-42-7 |
disitertide |
|
2933 99 80 |
227318-71-0 |
epetirimod |
|
2933 99 80 |
259793-96-9 |
favipiravir |
|
2933 99 80 |
871576-03-3 |
flovagatran |
|
2933 99 80 |
229305-39-9 |
golotimod |
|
2933 99 80 |
258818-34-7 |
larazotide |
|
2933 99 80 |
571170-77-9 |
laropiprant |
|
2933 99 80 |
616202-92-7 |
lorcaserin |
|
2933 99 80 |
868771-57-7 |
melogliptin |
|
2933 99 80 |
803712-67-6 |
obatoclax |
|
2933 99 80 |
404950-80-7 |
panobinostat |
|
2933 99 80 |
625114-41-2 |
piragliatin |
|
2933 99 80 |
74847-35-1 |
pyronaridine |
|
2933 99 80 |
872178-65-9 |
rabeximod |
|
2933 99 80 |
355151-12-1 |
rotigaptide |
|
2933 99 80 |
497221-38-2 |
rusalatide |
|
2933 99 80 |
187602-11-5 |
sofigatran |
|
2933 99 80 |
227318-75-4 |
sotirimod |
|
2933 99 80 |
402957-28-2 |
telaprevir |
|
2933 99 80 |
848084-83-3 |
tigapotide |
|
2933 99 80 |
393105-53-8 |
tiplasinin |
|
2933 99 80 |
620948-93-8 |
vabicaserin |
|
2933 99 80 |
794466-70-9 |
vernakalant |
|
2934 10 00 |
544417-40-5 |
capadenoson |
|
2934 10 00 |
302962-49-8 |
dasatinib |
|
2934 10 00 |
223132-37-4 |
inolitazon |
|
2934 10 00 |
241479-67-4 |
isavuconazool |
|
2934 10 00 |
338990-84-4 |
isavuconazoniumchloride |
|
2934 10 00 |
607723-33-1 |
lobeglitazon |
|
2934 10 00 |
280782-97-0 |
managlinatdialanetil |
|
2934 10 00 |
790299-79-5 |
masitinib |
|
2934 10 00 |
223673-61-8 |
mirabegron |
|
2934 10 00 |
501948-05-6 |
rosabulin |
|
2934 10 00 |
447406-78-2 |
sodelglitazar |
|
2934 10 00 |
760937-92-6 |
teneligliptin |
|
2934 20 80 |
848344-36-5 |
bentamapimod |
|
2934 20 80 |
870093-23-5 |
talarozool |
|
2934 99 90 |
320345-99-1 |
aclidiniumbromide |
|
2934 99 90 |
222551-17-9 |
adoprazine |
|
2934 99 90 |
207623-20-9 |
agatolimod |
|
2934 99 90 |
475479-34-6 |
aleglitazar |
|
2934 99 90 |
870524-46-2 |
amolimogeenbepiplasmide |
|
2934 99 90 |
875446-37-0 |
anacetrapib |
|
2934 99 90 |
250386-15-3 |
apadenoson |
|
2934 99 90 |
541550-19-0 |
apilimod |
|
2934 99 90 |
160707-69-7 |
apricitabine |
|
2934 99 90 |
147403-03-0 |
azilsartan |
|
2934 99 90 |
863031-21-4 |
azilsartanmedoxomil |
|
2934 99 90 |
757942-43-1 |
bederocin |
|
2934 99 90 |
627861-07-8 |
beperminogeenperplasmide |
|
2934 99 90 |
959961-96-7 |
bevasiranib |
|
2934 99 90 |
769901-96-4 |
capeserod |
|
2934 99 90 |
868540-17-4 |
carfilzomib |
|
2934 99 90 |
872847-66-0 |
cenersen |
|
2934 99 90 |
80295-38-1 |
conestat alfa |
|
2934 99 90 |
903916-27-8 |
custirsen |
|
2934 99 90 |
187865-22-1 |
derquantel |
|
2934 99 90 |
134379-77-4 |
dexelvucitabine |
|
2934 99 90 |
247046-52-2 |
dilopetine |
|
2934 99 90 |
480449-70-5 |
edoxaban |
|
2934 99 90 |
188181-42-2 |
elacytarabine |
|
2934 99 90 |
98819-76-2 |
esreboxetine |
|
2934 99 90 |
763903-67-9 |
fosalvudinetidoxil |
|
2934 99 90 |
172673-20-0 |
fosaprepitant |
|
2934 99 90 |
522664-63-7 |
ibodutant |
|
2934 99 90 |
405159-59-3 |
idrabiotaparinuxnatrium |
|
2934 99 90 |
188116-07-6 |
imepitoïne |
|
2934 99 90 |
335619-18-6 |
inakalant |
|
2934 99 90 |
1391-36-2 |
lancovutide |
|
2934 99 90 |
189059-71-0 |
lapaquistat |
|
2934 99 90 |
327026-93-7 |
lensiprazine |
|
2934 99 90 |
170632-47-0 |
lificiguat |
|
2934 99 90 |
852313-25-8 |
litenimod |
|
2934 99 90 |
1000120-98-8 |
mipomersen |
|
2934 99 90 |
62253-63-8 |
nepidermin |
|
2934 99 90 |
26833-87-4 |
omacetaxinemepesuccinaat |
|
2934 99 90 |
269718-84-5 |
pardoprunox |
|
2934 99 90 |
219923-85-0 |
pramiconazool |
|
2934 99 90 |
377727-87-2 |
preladenant |
|
2934 99 90 |
524684-52-4 |
prinaberel |
|
2934 99 90 |
865311-47-3 |
quarfloxin |
|
2934 99 90 |
869884-78-6 |
radezolid |
|
2934 99 90 |
496054-87-6 |
radiprodil |
|
2934 99 90 |
518048-05-0 |
raltegravir |
|
2934 99 90 |
787548-03-2 |
regrelor |
|
2934 99 90 |
820957-38-8 |
retosiban |
|
2934 99 90 |
572924-54-0 |
ridaforolimus |
|
2934 99 90 |
128517-07-7 |
romidepsin |
|
2934 99 90 |
93265-81-7 |
ropidoxuridine |
|
2934 99 90 |
151823-14-2 |
sapacitabine |
|
2934 99 90 |
379231-04-6 |
saracatinib |
|
2934 99 90 |
791635-59-1 |
simotaxel |
|
2934 99 90 |
119567-79-2 |
taribavirin |
|
2934 99 90 |
332012-40-5 |
telatinib |
|
2934 99 90 |
925681-61-4 |
trabedersen |
|
2934 99 90 |
189003-92-7 |
trelanserin |
|
2934 99 90 |
296251-72-4 |
velimogeenaliplasmide |
|
2934 99 90 |
904302-98-3 |
viquidacin |
|
2934 99 90 |
872525-61-6 |
votucalis |
|
2934 99 90 |
221877-54-9 |
zotarolimus |
|
2935 00 90 |
197904-84-0 |
apricoxib |
|
2935 00 90 |
769169-27-9 |
begacestat |
|
2935 00 90 |
414864-00-9 |
belinostat |
|
2935 00 90 |
313682-08-5 |
brecanavir |
|
2935 00 90 |
839673-52-8 |
cevoglitazar |
|
2935 00 90 |
358970-97-5 |
drinabant |
|
2935 00 90 |
865200-20-0 |
giripladib |
|
2935 00 90 |
464213-10-3 |
ibipinabant |
|
2935 00 90 |
173424-77-6 |
laromustine |
|
2935 00 90 |
398507-55-6 |
lodenafilcarbonaat |
|
2935 00 90 |
136564-68-6 |
masilukast |
|
2935 00 90 |
170569-88-7 |
mavacoxib |
|
2935 00 90 |
862189-95-5 |
mirodenafil |
|
2935 00 90 |
439687-69-1 |
nelivaptan |
|
2935 00 90 |
691852-58-1 |
nesbuvir |
|
2935 00 90 |
778576-62-8 |
oglemilast |
|
2935 00 90 |
444731-52-6 |
pazopanib |
|
2935 00 90 |
362505-84-8 |
relacatib |
|
2935 00 90 |
243984-11-4 |
resatorvid |
|
2935 00 90 |
519055-62-0 |
tasisulam |
|
2935 00 90 |
186497-07-4 |
zibotentan |
|
2936 29 00 |
104121-92-8 |
eldecalcitol |
|
2936 29 00 |
31690-09-2 |
levomefolinezuur |
|
2937 19 00 |
782500-75-8 |
albiglutide |
|
2937 19 00 |
348119-84-6 |
obinepitide |
|
2937 19 00 |
295350-45-7 |
ozarelix |
|
2937 19 00 |
275371-94-3 |
taspoglutide |
|
2937 19 00 |
218949-48-5 |
tesamorelin |
|
2937 19 00 |
22006-64-0 |
tridecactide |
|
2937 22 00 |
132245-57-9 |
dexamethasoncipecilaat |
|
2937 22 00 |
397864-44-7 |
fluticasonfuroaat |
|
2937 29 00 |
211254-73-8 |
lonaprisan |
|
2937 50 00 |
333963-42-1 |
cobiproston |
|
2937 50 00 |
172740-14-6 |
posaraprost |
|
2937 90 00 |
834153-87-6 |
elagolix |
|
2937 90 00 |
609799-22-6 |
tasimelteon |
|
2937 90 00 |
342577-38-2 |
velneperit |
|
2939 19 00 |
73232-52-7 |
methylnaltrexonbromide |
|
2939 59 00 |
136199-02-5 |
rolofylline |
|
2939 99 00 |
850607-58-8 |
darotropiumbromide |
|
2939 99 00 |
187852-63-7 |
delimotecan |
|
2940 00 00 |
9007-72-1 |
ferricarboxymaltose |
|
2940 00 00 |
442201-24-3 |
remogliflozinetabonaat |
|
2940 00 00 |
408504-26-7 |
sergliflozinetabonaat |
|
2941 90 00 |
467214-20-6 |
alvespimycine |
|
2941 90 00 |
677017-23-1 |
berubicine |
|
2941 90 00 |
229016-73-3 |
ceftarolinefosamil |
|
2941 90 00 |
318498-76-9 |
flopristin |
|
2941 90 00 |
145435-72-9 |
gamitromycine |
|
2941 90 00 |
325965-23-9 |
linopristin |
|
2941 90 00 |
857402-23-4 |
retaspimycine |
|
2941 90 00 |
305841-29-6 |
sagopilon |
|
2941 90 00 |
75747-14-7 |
tanespimycine |
|
2941 90 00 |
328898-40-4 |
tildipirosine |
|
2941 90 00 |
222400-20-6 |
tomopenem |
|
2941 90 00 |
63409-12-1 |
tylvalosine |
|
3001 90 91 |
9041-08-1 |
semuloparinnatrium |
|
3002 10 91 |
792921-10-9 |
abagovomab |
|
3002 10 91 |
910649-32-0 |
anrukinzumab |
|
3002 10 91 |
648904-28-3 |
bavituximab |
|
3002 10 91 |
402710-27-4 (lichte keten) 402710-25-2 (zware keten) |
canakinumab |
|
3002 10 99 |
945228-49-9 |
citatuzumab-bogatox |
|
3002 10 91 |
880486-59-9 |
dacetuzumab |
|
3002 10 91 |
615258-40-7 |
denosumab |
|
3002 10 91 |
762260-74-2 |
efungumab |
|
3002 10 91 |
89957-37-9 |
gantenerumab |
|
3002 10 91 |
680188-33-4 |
ibalizumab |
|
3002 10 91 |
477202-00-9 |
ipilimumab |
|
3002 10 91 |
640735-09-7 |
iratumumab |
|
3002 10 91 |
845816-02-6 |
lexatumumab |
|
3002 10 91 |
903512-50-5 |
lucatumumab |
|
3002 10 91 |
899796-83-9 |
milatuzumab |
|
3002 10 91 |
677010-34-3 |
motavizumab |
|
3002 10 91 |
676258-98-3 |
naptumomab-estafenatox |
|
3002 10 91 |
828933-51-3 |
nimotuzumab |
|
3002 10 91 |
949142-50-1 |
obinutuzumab |
|
3002 10 91 |
637334-45-3 |
ocrelizumab |
|
3002 10 91 |
881191-44-2 |
otelixizumab |
|
3002 10 91 |
372075-37-1 |
sontuzumab |
|
3002 10 91 |
705287-60-1 |
stamulumab |
|
3002 10 91 |
339086-80-5 |
tadocizumab |
|
3002 10 91 |
592557-43-2 (lichte keten) 592557-41-0 (zware keten) |
tenatumomab |
|
3002 10 91 |
876387-05-2 |
teplizumab |
|
3002 10 91 |
918127-53-4 |
tigatuzumab |
|
3002 10 91 |
745013-59-6 |
tremelimumab |
|
3002 10 91 |
339986-90-2 |
tucotuzumab-celmoleukin |
|
3002 10 91 |
728917-18-8 |
veltuzumab |
|
3002 10 91 |
896731-82-1 |
conatumumab |
|
3002 10 91 |
892553-42-3 |
etaracizumab |
|
3002 10 91 |
944548-38-3 |
foravirumab |
|
3002 10 91 |
944548-37-2 |
rafivirumab |
|
3002 10 91 |
880266-57-9 |
tanezumab |
|
3002 10 91 |
815610-63-0 |
ustekinumab |
|
3002 10 95 |
862111-32-8 |
aflibercept |
|
3002 10 95 |
845264-92-8 |
atacicept |
|
3002 10 95 |
909110-25-4 |
baminercept |
|
3002 10 95 |
9001-27-8 |
beroctocog alfa |
|
3002 10 95 |
879555-13-2 |
epoëtine kappa |
|
3002 10 95 |
762263-14-9 |
epoëtine thèta |
|
3002 10 95 |
501081-76-1 |
rilonacept |
|
3002 10 95 |
267639-76-9 |
romiplostim |
|
3002 10 95 |
869858-13-9 |
trombine alfa |
|
3002 10 95 |
897936-89-9 |
vatreptacog alfa (geactiveerd) |
|
3002 10 95 |
472960-22-8 |
albinterferon alfa-2b |
|
3002 10 95 |
869881-54-9 |
briobacept |
|
3002 10 95 |
606138-08-3 |
catridecacog |
|
3002 10 95 |
716840-32-3 |
denenicokin |
|
3002 10 95 |
931101-84-7 |
troplasminogeen alfa |
|
3002 10 99 |
934216-54-3 |
alacizumabpegol |
|
3002 20 00 |
181477-43-0 |
disomotide |
|
3002 20 00 |
181477-91-8 |
ovemotide |
|
3002 20 00 |
915019-08-8 |
tertomotide |
|
3002 20 00 |
295371-00-5 |
verpasepcaltespen |
|
3002 90 90 |
473553-86-5 |
alferminogeentadenovec |
|
3002 90 90 |
929881-05-0 |
alipogeentiparvovec |
|
3002 90 90 |
600735-73-7 |
contusugeenladenovec |
|
3002 90 90 |
851199-59-2 |
linaclotide |
|
3002 90 90 |
898830-54-1 |
sitimageenceradenovec |
|
3002 90 90 |
721946-42-5 |
transferrinealdifitox |
|
3507 90 90 |
9026-00-0 |
bucelipase alfa |
|
3507 90 90 |
885051-90-1 |
pegloticase |
|
3507 90 90 |
884604-91-5 |
velaglucerase alfa |
|
3911 90 99 |
892497-01-7 |
azoximerbromide |
BIJLAGE II
Lijst van voor- en achtervoegsels die, in combinatie met de INN's van bijlage 3 bij bijlage I bij Verordening (EEG) nr. 2658/87, de zouten, esters en hydraten van INN's aanduiden; op deze zouten, esters en hydraten zijn geen rechten van toepassing, mits zij onder dezelfde zescijferige GS-tariefonderverdeling vallen als de overeenkomstige INN
De verwijzingen naar „International Nonproprietary Names (INN) for pharmaceutical substances, names for radicals and groups, comprehensive list 2004” worden vervangen door verwijzingen naar „International Nonproprietary Names (INN) for pharmaceutical substances, names for radicals, groups and others, comprehensive list 2007”.
De volgende voor- en achtervoegsels worden toegevoegd aan de in bijlage 4 bij bijlage I bij Verordening (EEG) nr. 2658/87 opgenomen lijst:
|
Voor- of -achtervoegsel (voorkeursbenaming) |
Synoniemen |
Systematische naam, indien verschillend |
|
alanetil (INNRG) |
|
[(S)-1-ethoxy-1-oxo-propaan-2-yl]amino (INNCN) |
|
alaninaat (INNRG) |
|
L-alaninaat (INNCN) |
|
alapivoxil (INNRG) |
|
L-alanyl, [(2,2-dimethylpropanoyl)oxy]methyl (INNCN) |
|
aldifitox (INNRG) |
|
(4-iminobutaan-1,4-diyl)sulfaandiyl[(3RS)-2,5-dioxopyrrolidine-1,3-diyl]-1,3-fenyleencarbonyl als N-benzoylderivaat gebonden aan een primaire aminogroep van difterie[550-L-fenylalanine]toxine van Corynebacterium diphtheriae-(26-560)-peptide (INNCN) |
|
besudotox (INNRG) |
|
L-lysyl-L-alanyl-L-serylglycylglycine (linker) fusie-eiwit met de-(365-380)-[Asn364,Val407,Ser515,Gln590,Gln606,Arg613]exotoxine A (Pseudomonas aeruginosa)-(251-613)-peptide (toxine waarvan gebied IA en de eerste 16 resten van gebied IB zijn verwijderd) (INNCN) |
|
ceribaat (INNRG) |
|
rac-2,3-dihydroxypropylcarbonaat (ester) (INNCN) |
|
cipecilaat (INNRG) |
|
cyclohexaancarboxylaat (ester), cyclopropaancarboxylaat (ester) (INNCN) |
|
gedalanateerd (INNRG) |
|
de-B30-alanine (INNCN) |
|
enacarbil (INNRG) |
|
{rac-1-[(2-methylpropanoyl)oxy]ethoxy} carbonyl (INNCN) |
|
estafenatox (INNRG) |
|
glycylglycyl-L-proline (linker) fusie-eiwit met enterotoxine type A (Staphylococcus aureus)-(1-33)-peptidyl-L-seryl[Ser36,Ser37,Glu38,Lys39,Ala41,Thr46,Thr71,Ala72,Ser75,Glu76,Glu78,Ser80,Ser81,Thr214,Ser217,Thr219, Ser220,Ser222,Ser224]enterotoxine type E (Staphylococcus aureus)-(32-230)-peptide (synthetisch superantigeen SEA/E-120) (INNCN) |
|
etexilaat (INNRG) |
|
ethyl, (hexyloxy)carbonyl |
|
fosamil (INNRG) |
|
fosfono (INNCN) |
|
glucuronide (INNRG) |
|
β-D-glucopyranosiduronzuur [-oside] (INNCN) |
|
medocaril (INNRG) |
|
[(5-methyl-2-oxo-1,3-dioxool-4-yl)methoxy]carbonyl (INNCN) |
|
paptox (INNRG) |
|
eiwit PAP (Phytolacca americana antiviraal) (INNCN) |
|
placarbil (INNRG) |
|
(R)-2-methyl-1-[(2-methylpropanoyl)oxy]propoxy} carbonyl) (INNCN) |
De systematische naam van het volgende voor- of achtervoegsel wordt als volgt gewijzigd:
|
Voor- of -achtervoegsel (voorkeursbenaming) |
Synoniemen |
Systematische naam, indien verschillend |
|
aritox (INNRG) |
|
ricine A-keten (INNCN) |
BIJLAGE III
Lijst van farmaceutische tussenproducten, dat wil zeggen verbindingen die bij de vervaardiging van farmaceutische eindproducten worden gebruikt, die moeten worden toegevoegd aan de lijst van producten waarop geen rechten van toepassing zijn in bijlage 6 bij bijlage I bij Verordening (EEG) nr. 2658/87
|
GN code |
CAS-nummer |
Naam |
|
2843 29 00 |
22199-08-2 |
[4-amino-N-(pyrimidine-2(1H)-ylideen-κN1)benzeensulfonamidato-κO]zilver |
|
2905 39 95 |
281214-27-5 |
(2R,3R)-2,3-dimethylbutaan-1,4-diylbis(4-methylbenzeensulfonaat) |
|
2905 59 98 |
441002-17-1 |
4-chloorbutyl 2-nitrobenzeensulfonaat |
|
2909 30 90 |
92878-95-0 |
2-(3-chloorpropoxy)-1-methoxy-4-nitrobenzeen |
|
2909 30 |
503070-57-3 |
2-({2-[(6-broomhexyl)oxy]ethoxy}methyl)-1,3-dichloorbenzeen |
|
2909 30 |
461432-23-5 |
4-(5-broom-2-chloorbenzyl)fenylethylether |
|
2909 49 80 |
185954-75-0 |
(3R)-3-methoxydecaan-1-ol |
|
2909 49 80 |
85309-91-7 |
2-[(2,6-dichloorbenzyl)oxy]ethanol |
|
2909 49 80 |
160969-03-9 |
2-[2-(2,2,2-trifluorethoxy)fenoxy]ethylmethaansulfonaat |
|
2909 50 00 |
167145-13-3 |
2-[2-(3-methoxyfenyl)ethyl]fenol |
|
2910 20 00 |
15448-47-2 |
(2R)-2-methyloxiraan |
|
2910 90 00 |
62600-71-9 |
(2R)-2-(3-chloorfenyl)oxiraan |
|
2910 90 00 |
702687-42-1 |
(2R)-2-[(5-broom-2,3-difluorfenoxy)methyl]oxiraan |
|
2910 90 00 |
683276-64-4 |
[(2R)-2-methyloxiraan-2-yl]methyl-4-nitrobenzeensulfonaat |
|
2913 00 00 |
90035-34-0 |
4′-(trifluormethyl)bifenyl-4-carbaldehyd |
|
2914 40 90 |
17752-16-8 |
(3β)-3-hydroxycholest-5-een-24-on |
|
2914 50 00 |
974-23-2 |
(3β,16α)-3-hydroxy-16,17-epoxypregn-5-een-20-on |
|
2914 70 00 |
13054-81-4 |
4-chloorheptaan-3,5-dion |
|
2914 70 00 |
10226-30-9 |
6-chloorhexaan-2-on |
|
2915 60 90 |
53064-79-2 |
joodmethylpivalaat |
|
2915 90 00 |
22328-90-1 |
(3R)-3-methylhexaanzuur |
|
2915 90 00 |
1069-66-5 |
natrium-2-propylpentanoaat |
|
2916 20 00 |
211515-46-7 |
1-(2-ethylbutyl)cyclohexaancarbonylchloride |
|
2916 20 00 |
381209-09-2 |
1-(2-ethylbutyl)cyclohexaancarbonzuur |
|
2916 20 00 |
7077-05-6 |
trans-4-(propaan-2-yl)cyclohexaancarbonzuur |
|
2916 39 00 |
21900-39-0 |
5-fluor-2-methylbenzoylchloride |
|
2916 39 00 |
17625-03-5 |
natriumhydrogeen-3-sulfonatobenzoaat |
|
2917 19 90 |
76-72-2 |
diethyl-ethyl(pentaan-2-yl)propaandioaat |
|
2918 29 00 |
376592-58-4 |
5′-chloor-2′-hydroxy-3′-nitrobifenyl-3-carbonzuur |
|
2918 99 90 |
709031-28-7 |
(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)(oxo)azijnzuur |
|
2918 99 90 |
35480-52-5 |
2,5-bis(2,2,2-trifluorethoxy)benzoëzuur |
|
2918 99 90 |
4651-67-6 |
(3α,5β)-3-hydroxy-7-oxocholaan-24-zuur |
|
2918 99 90 |
52179-28-9 |
ethyl-2-[4-(2,2-dichloorcyclopropyl)fenoxy]-2-methylpropanoaat |
|
2918 99 90 |
530141-60-7 |
methyl-3-(5-{[4-(cyclopentyloxy)-2-hydroxyfenyl]carbonyl}-2-hydroxyfenyl)propanoaat |
|
2920 90 10 |
91526-18-0 |
4-(hydroxymethyl)-5-methyl-1,3-dioxool-2-on |
|
2921 49 00 |
334477-60-0 |
(1R)-1-[3,5-bis(trifluormethyl)fenyl]-N-methylethaanamine |
|
2921 49 00 |
376608-71-8 |
(1R,2S)-2-(3,4-difluorfenyl)cyclopropaanaminium-(2R)-fenylhydroxyethanoaat |
|
2921 49 00 |
1034457-07-2 |
2-(2,3-dihydro-1H-indeen-2-yl)propaan-2-aminehydrochloride |
|
2921 49 00 |
945717-05-5 |
2-(4-chloor-3-ethylfenyl)ethaanaminehydrochloride |
|
2921 49 00 |
89-97-4 |
2-chloorbenzylamine |
|
2921 49 00 |
945717-43-1 |
N-(4-tert-butylbenzyl)-2-(4-chloor-3-ethylfenyl)ethaanamine |
|
2921 51 90 |
150812-21-8 |
N4-[(4-fluorfenyl)methyl]-2-nitro-1,4-benzeendiamine |
|
2922 19 85 |
1035455-90-3 |
(2R)-1-(5-broom-2,3-difluorfenoxy)-3-{[1-(2,3-dihydro-1H-indeen-2-yl)-2-methylpropaan-2-yl]amino}propaan-2-olhydrochloride |
|
2922 19 85 |
848949-85-9 |
[2-(chloormethyl)-4-(dibenzylamino)fenyl]methanolhydrochloride |
|
2922 19 85 |
133-51-7 |
antimoonzuur - 1-deoxy-1-(methylamino)-D-glucitol (1:1) |
|
2922 19 85 |
1035455-87-8 |
ethyl-(2E)-3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-indeen-2-yl)-2-methylpropaan-2-yl]amino}-2-hydroxypropyl]oxy}-4,5-difluorfenyl)prop-2-enoaathydrochloride |
|
2922 19 85 |
702686-97-3 |
ethyl-3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-indeen-2-yl)-2-methylpropaan-2-yl]amino}-2-hydroxypropyl]oxy}-4,5-difluorfenyl)propanoaathydrochloride |
|
2922 29 00 |
20059-73-8 |
2-[4-(aminomethyl)fenoxy]-N,N-dimethylethaanamine |
|
2922 49 85 |
848133-35-7 |
(2E)-4-(dimethylamino)but-2-eenzuurhydrochloride |
|
2922 49 85 |
610300-07-7 |
(3S,5R)-3-amino-5-methyloctaanzuur |
|
2922 49 85 |
610300-00-0 |
(3S,5R)-3-amino-5-methyloctaanzuurhydrochloride |
|
2922 49 85 |
143785-86-8 |
4-(1-aminocyclopropyl)-2,3,5-trifluorbenzoëzuur |
|
2922 49 85 |
0-00-0 |
4-fluor-L-leucine - ethylhydrogeensulfaat (1:1) |
|
2922 49 85 |
39068-93-4 |
methyl-2-(dimethylamino)-2-fenylbutanoaat |
|
2922 49 85 |
168619-25-8 |
methyl-3′-aminobifenyl-3-carboxylaat |
|
2922 49 85 |
82834-12-6 |
N-[(2S)-1-ethoxy-1-oxopentaan-2-yl]-L-alanine |
|
2922 49 85 |
94133-84-3 |
natrium-2-amino-2-fenylbutanoaat |
|
2922 50 00 |
503070-58-4 |
trifenylazijnzuur - 4-{(1R)-2-[(6-{2-[(2,6-dichloorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)fenol (1:1) |
|
2924 19 00 |
62009-47-6 |
2-aminomalonamide |
|
2924 19 00 |
7355-58-0 |
N-(2-chloorethyl)aceetamide |
|
2924 29 98 |
361442-00-4 |
{2-[(tert-butoxycarbonyl)amino]-3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl}azijnzuur |
|
2924 29 98 |
266993-72-0 |
2,3-diaminobenzamidedihydrochloride |
|
2924 29 98 |
168080-49-7 |
2-chloor-4-{[(5-fluor-2-methylfenyl)carbonyl]amino}benzoëzuur |
|
2924 29 98 |
317374-08-6 |
2-methyl-4-{[(2-methylfenyl)carbonyl]amino}benzoëzuur |
|
2924 29 98 |
143785-84-6 |
4-(1-carbamoylcyclopropyl)-2,3,5-trifluorbenzoëzuur |
|
2924 29 98 |
143785-87-9 |
4-[1-(acetylamino)cyclopropyl]-2,3,5-trifluorbenzoëzuur |
|
2924 29 98 |
108166-22-9 |
4-{[(2-methylfenyl)carbonyl]amino}benzoëzuur |
|
2924 29 98 |
150812-23-0 |
ethyl-{4-[(4-fluorbenzyl)amino]-2-nitrofenyl}carbamaat |
|
2924 29 98 |
22316-45-6 |
ethyl-3-[(5-chloor-2-nitrofenyl)(fenyl)amino]-3-oxopropanoaat |
|
2924 29 98 |
316173-29-2 |
methyl-(1S,2S,3S,4R)-3-[(1S)-1-amino-2-ethylbutyl]-4-[(tert-butoxycarbonyl)amino]-2-hydroxycyclopentaancarboxylaat |
|
2924 29 98 |
1142-20-7 |
N-benzyloxycarbonyl-L-alanine |
|
2924 29 98 |
84996-93-0 |
N-cyclohexyl-5-hydroxypentaanamide |
|
2924 29 98 |
579494-66-9 |
propyl-{4-[2-(diethylamino)-2-oxoethoxy]-3-ethoxyfenyl}acetaat |
|
2925 19 95 |
265136-65-0 |
ethyl-3-amino-4-[2-(1,3-dioxo-1,3-dihydro-2H-isoindool-2-yl)ethoxy]but-2-enoaat |
|
2926 90 95 |
855425-38-6 |
1-(2-ethylbutyl)cyclohexaancarbonitril |
|
2926 90 95 |
846023-24-3 |
2-cyaan-N-(2,4-dichloor-5-methoxyfenyl)aceetamide |
|
2926 90 95 |
591769-05-0 |
3-cyclopentylprop-2-eennitril |
|
2926 90 95 |
20099-89-2 |
4-(broomacetyl)benzonitril |
|
2926 90 95 |
474554-45-5 |
4,5-diethoxy-3-fluorbenzeen-1,2-dicarbonitril |
|
2926 90 95 |
79370-78-8 |
5-hydroxybenzeen-1,3-dicarbonitril |
|
2926 90 95 |
139481-28-0 |
methyl-2-{[(2′-cyaanbifenyl-4-yl)methyl]amino}-3-nitrobenzoaat |
|
2928 00 90 |
860035-10-5 |
1-({[(2,5-dioxopyrrolidine-1-yl)oxy]carbonyl}oxy)ethyl-2-methylpropanoaat |
|
2928 00 90 |
910656-45-0 |
2-hydroxy-2-(trifluormethyl)butaanhydrazide |
|
2928 00 90 |
95759-10-7 |
4-chloor-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutaanzuur |
|
2928 00 90 |
473927-63-8 |
ethyl-(2Z)-chloor[2-(4-methoxyfenyl)hydrazinylideen]ethanoaat |
|
2928 00 90 |
158671-29-5 |
N,2-dihydroxy-4-methylbenzamide |
|
2928 00 90 |
84080-68-2 |
tert-butyl-(2Z)-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoaat |
|
2928 00 90 |
268544-50-9 |
tert-butyl-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoaat |
|
2930 90 99 |
13459-62-6 |
{2-[(4-chloorfenyl)sulfanyl]fenyl}azijnzuur |
|
2930 90 99 |
211513-21-2 |
1-(2-ethylbutyl)-N-(2-sulfanylfenyl)cyclohexaancarboxamide |
|
2930 90 99 |
860035-07-0 |
1-{[(methylsulfanyl)carbonyl]oxy}ethyl-2-methylpropanoaat |
|
2930 90 99 |
893407-18-6 |
2,2,2-trifluor-1-[4′-(methylsulfonyl)bifenyl-4-yl]ethanon |
|
2930 90 99 |
60759-00-4 |
3,4-diethoxybenzeencarbothioamide |
|
2930 90 99 |
21048-05-5 |
N-methylbenzeencarbothiohydrazide |
|
2931 00 99 |
13682-94-5 |
(2-broomethenyl)(trimethyl)silaan |
|
2931 00 99 |
914922-89-7 |
(2R,4R)-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-N-methoxy-N,2-dimethyl-7-oxoheptanamide |
|
2931 00 99 |
914922-88-6 |
(2R,4R)-4-{[tert-butyl(dimethyl)silyl]oxy}-N-methoxy-N,2-dimethyloct-7-eenamide |
|
2931 00 99 |
871355-80-5 |
(4R)-2-broom-7-{[tert-butyl(difenyl)silyl]oxy}hept-1-een-4-yl-4-methylbenzeensulfonaat |
|
2931 00 99 |
89694-48-4 |
(5-chloor-2-methoxyfenyl)boronzuur |
|
2931 00 99 |
701278-08-2 |
[(1R,5S)-5-[fenyldimethylsilyl]-2-{[(2-methoxypropaan-2-yl)oxy]methyl}cyclopent-2-een-1-yl]methanol |
|
2931 00 99 |
701278-09-3 |
{(4S,5R)-5-[(benzyloxy)methyl]-4-[fenyldimethylsilyl]cyclopent-1-een-1-yl}methanol |
|
2931 00 99 |
796967-18-5 |
1-(2-fluor-5-methylfenyl)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolaan-2-yl)fenyl]ureum |
|
2931 00 99 |
172732-52-4 |
2-(1,3,2-dioxaborinaan-2-yl)benzonitril |
|
2931 00 99 |
185411-12-5 |
methyl-3-(trimethylsilyl)pent-4-enoaat |
|
2932 19 00 |
253128-10-8 |
(1S)-1,5:7,10-dianhydro-12,13-bis-O-[tert-butyl(dimethyl)silyl]-2,3,4,6,8,11-hexadeoxy-1-{2-[(2S,5S)-5-(3-hydroxypropyl)-3-methylideentetrahydrofuran-2-yl]ethyl}-3-methyl-9-O-methyl-4-methylideen-8-[(fenylsulfonyl)methyl]-D-arabino-D-altro-tridecitol |
|
2932 19 00 |
441045-17-6 |
(1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-bis(methyleen)-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018, 22.029,36.031,35]hentetracontaan-24-on-methaansulfonaat |
|
2932 29 85 |
916069-80-2 |
(4S)-4-(fluormethyl)dihydrofuran-2(3H)-on |
|
2932 29 85 |
63106-93-4 |
1-fenyl-3-oxabicyclo[3.1.0]hexaan-2-on |
|
2932 29 85 |
7734-80-7 |
2-oxo-2H-chromeen-6-carbonzuur |
|
2932 29 85 |
0-00-0 |
4-(4-fluorfenyl)-7-(isothiocyanatomethyl)-2H-chromeen-2-on |
|
2932 29 85 |
947408-91-5 |
6-[(2,4-dihydroxyfenyl)carbonyl]-2H-chromeen-2-on |
|
2932 29 85 |
947408-90-4 |
6-[(2,4-dimethoxyfenyl)carbonyl]-2H-chromeen-2-on |
|
2932 99 00 |
452342-08-4 |
(1R)-2-(benzylamino)-1-(2,2-dimethyl-4H-1,3-benzodioxine-6-yl)ethanol |
|
2932 99 00 |
99541-23-8 |
(1R,2S,3R,4R,5R)-4-azido-2-{[(4aR,6S,7R,8S,8aR)-7,8-bis(benzyloxy)-2-fenylhexahydropyrano[3,2-d][1,3]dioxine-6-yl]oxy}-6,8-dioxabicyclo[3.2.1]oct-3-ylacetaat |
|
2932 99 00 |
461432-25-7 |
(1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[4-chloor-3-(4-ethoxybenzyl)fenyl]-D-glucitol |
|
2932 99 00 |
196597-79-2 |
(2E)-1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylideenethaannitril |
|
2932 99 00 |
3308-94-9 |
2-(3-chloorpropyl)-2-(4-fluorfenyl)-1,3-dioxolaan |
|
2932 99 00 |
274693-53-7 |
[(3aR,4S,6R,6aS)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxool-4-yl]carbamaat |
|
2932 99 00 |
185954-98-7 |
[6(2Z,3R)]-3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-(3-methoxydecyl)-6-methyl-2-[(1-oxo-11-octadecenyl)amino]-4-O-fosfono-β-D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]-α-D-glucopyranose-1-(dihydrogeenfosfaat), tetranatriumzout |
|
2932 99 00 |
136172-58-2 |
1,6-di-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-D-glucopyranose |
|
2932 99 00 |
196597-80-5 |
2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethaanaminehydrochloride |
|
2932 99 00 |
666860-59-9 |
2-amino-2-oxoethyl{3-[trans-5-(6-methoxynaftaleen-1-yl)-1,3-dioxaan-2-yl]propyl}carbamaat |
|
2932 99 00 |
117661-72-0 |
5-(chloormethyl)-6-methyl-1,3-benzodioxool |
|
2932 99 00 |
959624-24-9 |
4-fenyl-6-(hydroxymethyl)-3,4-dihydro-2H-chromeen-2-ol |
|
2932 99 00 |
960404-59-5 |
but-2-yn-1,4-diol - methyl-1-C-[4-chloor-3-(4-ethoxybenzyl)fenyl]-α-D-glucopyranoside (1:1) |
|
2932 99 00 |
15826-37-6 |
dinatrium-5,5′-[(2-hydroxypropaan-1,3-diyl)bis(oxy)]bis(4-oxo-4H-chromeen-2-carboxylaat) |
|
2932 99 00 |
204254-84-2 |
ethyl-(3aR,7R,7aR)-2,2-dimethyl-7-[(methylsulfonyl)oxy]-3a,6,7,7a-tetrahydro-1,3-benzodioxool-5-carboxylaat |
|
2932 99 00 |
99541-26-1 |
methyl-(2S,3S,4S,5S,6S)-6-{[(1S,2S,3S,4R,5R)-3-(acetyloxy)-4-azido-6,8-dioxabicyclo[3.2.1]oct-2-yl]methyl}-4,5-bis(benzyloxy)-3-hydroxytetrahydro-2H-pyran-2-carboxylaat |
|
2932 99 00 |
114869-97-5 |
methyl-6-O-acetyl-4-O-(2-O-acetyl-3-O-benzyl-6-methyl-α-L-idopyranuronosyl)-3-O-benzyl-2-{[(benzyloxy)carbonyl]amino}-2-deoxy-α-D-glucopyranoside |
|
2933 19 90 |
1035677-60-1 |
(4S)-3-(4-chloorfenyl)-4-fenyl-N-methyl-4,5-dihydro-1H-pyrazool-1-carboximidamide-2,3-dihydroxybutaandioaat |
|
2933 19 90 |
18048-64-1 |
2-(3,4-dimethylfenyl)-5-methyl-2,4-dihydro-3H-pyrazool-3-on |
|
2933 19 90 |
1035675-24-1 |
3-(4-chloorfenyl)-4-fenyl-N-methyl-4,5-dihydro-1H-pyrazool-1-carboximidamide |
|
2933 19 90 |
1028026-83-6 |
5-methyl-1-(propaan-2-yl)-4-[4-(propaan-2-yloxy)benzyl]-1,2-dihydro-3H-pyrazool-3-on |
|
2933 19 90 |
473921-12-9 |
5-{[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazool-4-yl]oxy}benzeen-1,3-dicarbonitril |
|
2933 29 90 |
65902-59-2 |
2-broom-4-nitro-1H-imidazool |
|
2933 29 90 |
57531-37-0 |
2-chloor-4-nitro-1H-imidazool |
|
2933 29 90 |
1000164-35-1 |
3-(1,1-dimethylethyl)-N-[(9H-fluoreen-9-ylmethoxy)carbonyl]-1-(trifenylmethyl)-L-histidyl-2-methylalanyl-L-α-glutamylglycine |
|
2933 29 90 |
152074-97-0 |
L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L-fenylalanyl-L-fenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-valyl-L-treonyl-L-prolyl-L-arginyl-L-treonine |
|
2933 29 90 |
781666-30-6 |
L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L-fenylalanyl-L-fenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-valyl-L-treonyl-L-prolyl-L-arginyl-L-treoninetetraacetaat |
|
2933 29 90 |
451470-33-0 |
methyl-3′-(2-methyl-4,5-dihydro-1H-imidazool-1-yl)bifenyl-3-carboxylaat |
|
2933 39 99 |
925978-49-0 |
(+)-5-[6-(1-methyl-1H-pyrazool-4-yl)pyridine-3-yl]-1-azabicyclo[3.2.1]octaan |
|
2933 39 99 |
876170-44-4 |
(1S,5S)-3-(5,6-dichloorpyridine-3-yl)-3,6-diazabicyclo[3.2.0]heptaanbenzeensulfonaat |
|
2933 39 99 |
741705-70-4 |
(2R)-fenyl[(2R)-piperidine-2-yl]ethaanzuurhydrochloride |
|
2933 39 99 |
414910-13-7 |
(2S)-fenylhydroxyethaanzuur - (2R)-2-(4-fluor-2-methylfenyl)piperidine-4-on (1:1) |
|
2933 39 99 |
0-00-0 |
(3aR,6aR)-1-(pyridine-3-yl)octahydropyrrolo[3,4-b]pyrrool-4-methylbenzeensulfonaat |
|
2933 39 99 |
370882-57-8 |
(3aR,6aR)-1-(pyridine-3-yl)octahydropyrrolo[3,4-b]pyrrooldihydrochloride |
|
2933 39 99 |
334618-23-4 |
(3R)-piperidine-3-aminedihydrochloride |
|
2933 39 99 |
1062580-52-2 |
(3R,4R)-1-benzyl-N,4-dimethylpiperidine-3-aminedihydrochloride |
|
2933 39 99 |
27262-47-1 |
(S)-1-butyl-N-(2,6-dimethylfenyl)piperidine-2-carboxamide |
|
2933 39 99 |
105812-81-5 |
[(3S,4R)-4-(4-fluorfenyl)-1-methylpiperidine-3-yl]methanol |
|
2933 39 99 |
876068-51-8 |
[(3S,4S)-4-amino-1-(5,6-dichloorpyridine-3-yl)pyrrolidine-3-yl]methanol |
|
2933 39 99 |
871022-14-9 |
1-({4-[({[2-oxo-3-(propaan-2-yl)-2,3-dihydro-1H-benzimidazool-1-yl]carbonyl}amino)methyl]piperidine-1-yl}methyl)cyclobutaancarbonzuur |
|
2933 39 99 |
5421-92-1 |
1-(pyridine-4-yl)pyridiniumchloridehydrochloride |
|
2933 39 99 |
272776-12-2 |
1,1′-binaftaleen-2,2′-diol -5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridine-2-yl)methyl]sulfinyl}-1H-benzimidazool (1:1) |
|
2933 39 99 |
871022-19-4 |
1-[(4-{[(tert-butoxycarbonyl)amino]methyl}piperidine-1-yl)methyl]cyclobutaancarbonzuur |
|
2933 39 99 |
3613-73-8 |
2,8-dimethyl-5-[2-(6-methylpyridine-3-yl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indool |
|
2933 39 99 |
179687-79-7 |
2-[(2-chloor-4-nitrofenoxy)methyl]pyridine |
|
2933 39 99 |
122321-04-4 |
2-[methyl(pyridine-2-yl)amino]ethanol |
|
2933 39 99 |
945405-37-8 |
2-methyl-3-[(2S)-pyrrolidine-2-ylmethoxy]pyridine-2,3-dihydroxybutaandioaat |
|
2933 39 99 |
936637-40-0 |
3,3′-piperidine-1,4-diyldipropaan-1-ol-4-methylbenzeensulfonaat |
|
2933 39 99 |
88150-62-3 |
3-ethyl-5-methyl-4-(2-chloorfenyl)-2-{[2-(1,3-dioxo-1,3-dihydro-2H-isoindool-2-yl)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylaat |
|
2933 39 99 |
84100-54-9 |
4-(ethylamino)piperidine-4-carboxamide |
|
2933 39 99 |
873546-30-6 |
4,4′-[piperidine-1,4-diylbis(propaan-3,1-diyloxy)]bis(N′-hydroxybenzeencarboximidamide) |
|
2933 39 99 |
873546-74-8 |
4,4′-[piperidine-1,4-diylbis(propaan-3,1-diyloxy)]bis[N′-(acetyloxy)benzeencarboximidamide] |
|
2933 39 99 |
873546-38-4 |
4,4′-[piperidine-1,4-diylbis(propaan-3,1-diyloxy)]dibenzeencarboximidamidetrihydrochloride-pentahydraat |
|
2933 39 99 |
873546-80-6 |
4,4′-[piperidine-1,4-diylbis(propaan-3,1-diyloxy)]dibenzonitril |
|
2933 39 99 |
78750-61-5 |
4-[(3-nitropyridine-2-yl)amino]fenol |
|
2933 39 99 |
866109-93-5 |
4-{4-[4-(trifluormethoxy)fenoxy]piperidine-1-yl}fenol-4-methylbenzeensulfonaat |
|
2933 39 99 |
927889-51-8 |
4-broom-2,6-diethylpyridine-4-methylbenzeensulfonaat |
|
2933 39 99 |
691882-47-0 |
4-hydroxybenzoëzuur - (2S,4E)-N-methyl-5-[5-(propaan-2-yloxy)pyridine-3-yl]pent-4-een-2-amine (1:1) |
|
2933 39 99 |
876068-46-1 |
5,6-dichloor-N-(2,2-dimethoxyethyl)pyridine-3-amine |
|
2933 39 99 |
1072-98-6 |
5-chloorpyridine-2-amine |
|
2933 39 99 |
298692-34-9 |
6-(chlooracetyl)pyridine-2-carbonzuur |
|
2933 39 99 |
550349-58-1 |
7-chloor-3-(6-methoxypyridine-3-yl)-N,N,5-trimethyl-4-oxo-4,5-dihydro-3H-pyridazino[4,5-b]indool-1-carboxamide |
|
2933 39 99 |
414909-98-1 |
benzyl-2-(4-fluor-2-methylfenyl)-4-oxo-3,4-dihydropyridine-1(2H)-carboxylaat |
|
2933 39 99 |
56880-11-6 |
ethyl-[(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl)acetaat |
|
2933 39 99 |
548797-97-3 |
N-(2-{[(2S)-3-{[1-(4-chloorbenzyl)piperidine-4-yl]amino}-2-hydroxy-2-methylpropyl]oxy}-4-hydroxyfenyl)aceetamide |
|
2933 39 99 |
0-00-0 |
N-[(S)-1-azabicyclo[2.2.2]oct-2-yl(fenyl)methyl]-2,6-dichloor-3-(trifluormethyl)benzamidehydrochloride |
|
2933 39 99 |
329003-65-8 |
natriumhydrogeen[1-hydroxy-1-fosfono-2-(pyridine-3-yl)ethyl]fosfonaat-hemipentahydraat |
|
2933 49 10 |
417716-92-8 |
4-{3-chloor-4-[(cyclopropylcarbamoyl)amino]fenoxy}-7-methoxychinoline-6-carboxamidemethaansulfonaat |
|
2933 49 90 |
503291-53-0 |
2-ethylbutyl-(3S,4aS,6S,8aR)-6-[3-chloor-2-(1H-tetrazool-5-yl)fenoxy]decahydro-3-isochinolinecarboxylaat-4-methylbenzeensulfonaat |
|
2933 49 90 |
103733-32-0 |
benzyl-(3S)-6,7-dimethoxy-1,2,3,4-tetrahydroisochinoline-3-carboxylaathydrochloride |
|
2933 49 90 |
503293-98-9 |
(3S,4aS,6S,8aR)-6-hydroxy-2-(methoxycarbonyl)decahydroisochinoline-3-carbonzuur |
|
2933 49 90 |
503290-66-2 |
(3S,4aS,6S,8aR)-6-[3-chloor-2-(2H-tetrazool-5-yl)fenoxy]decahydro-3-isochinolinecarbonzuurhydrochloride |
|
2933 49 90 |
134388-95-7 |
(3S,4aS,8aR)-2-(methoxycarbonyl)-6-oxodecahydroisochinoline-3-carbonzuur - (1R)-1-fenylethaanamine (1:1) |
|
2933 49 90 |
868210-14-4 |
4-(4-{[(2S,4R)-4-[acetyl(4-chloorfenyl)amino]-2-methyl-3,4-dihydrochinoline-1(2H)-yl]carbonyl}fenoxy)-2,2-dimethylbutaanzuur |
|
2933 49 90 |
00-00-0 |
methyl-2-[(3R)-3-{3-[(E)-2-(7-chloorchinoline-2-yl)ethenyl]fenyl}-3-({[1-(hydroxymethyl)cyclopropyl]methyl}sulfanyl)propyl]benzoaathydrochloride |
|
2933 49 90 |
848133-76-6 |
N-(4-chloor-3-cyaan-7-ethoxychinoline-6-yl)aceetamide |
|
2933 59 95 |
869490-23-3 |
(3,3-difluorpyrrolidine-1-yl){(2S,4S)-4-[4-(pyrimidine-2-yl)piperazine-1-yl]pyrrolidine-2-yl}methanon |
|
2933 59 95 |
941685-40-1 |
(3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1H-pyrazool-1-yl]propaannitril |
|
2933 59 95 |
941678-49-5 |
(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1H-pyrazool-1-yl]propaannitril |
|
2933 59 95 |
941685-41-2 |
(3S)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1H-pyrazool-1-yl]propaannitril |
|
2933 59 95 |
957187-34-7 |
[(8R)-8-(3,5-difluorfenyl)-10-oxo-6,9-diazaspiro[4.5]dec-9-yl]azijnzuur |
|
2933 59 95 |
356058-42-9 |
{2-[(4-fluorbenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidine-1-yl}azijnzuur |
|
2933 59 95 |
0-00-0 |
2,3-dihydroxy-2,3-bis(fenylcarbonyl)butaandizuur - ethyl-[(8R)-8-(3,5-difluorfenyl)-10-oxo-6,9-diazaspiro[4.5] dec-9-yl]acetaat (1:1) |
|
2933 59 95 |
90213-66-4 |
2,4-dichloor-7H-pyrrolo[2,3-d]pyrimidine |
|
2933 59 95 |
3934-20-1 |
2,4-dichloorpyrimidine |
|
2933 59 95 |
451487-18-6 |
2-[(4-fluorbenzyl)sulfanyl]-1,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidine-4-on |
|
2933 59 95 |
865758-96-9 |
2-[(6-chloor-3-methyl-2,4-dioxo-3,4-dihydropyrimidine-1(2H)-yl)methyl]benzonitril |
|
2933 59 95 |
934815-71-1 |
2-[3-(6-{[2-(2,4-dichloorfenyl)ethyl]amino}-2-methoxypyrimidine-4-yl)fenyl]-2-methylpropaanzuur, fosfaat |
|
2933 59 95 |
722543-31-9 |
2-{ethyl[3-({4-[(5-{2-[(3-fluorfenyl)amino]-2-oxoethyl}-1H-pyrazool-3-yl)amino]chinazoline-7-yl}oxy)propyl]amino}ethyldihydrogeenfosfaat |
|
2933 59 95 |
1032066-96-8 |
2-amino-9-{(1S,3R,4S)-3-[(benzyloxy)methyl]-4-[fenyldimethylsilyl]-2-methylideencyclopentyl}-1,9-dihydro-6H-purine-6-on - methaansulfonaat (2:1) |
|
2933 59 95 |
540737-29-9 |
3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino]piperidine-1-yl}-3-oxopropaannitril 2-hydroxypropaan-1,2,3-tricarboxylaat |
|
2933 59 95 |
1137917-12-4 |
3-{[6-(ethylsulfonyl)pyridine-3-yl]oxy}-5-{[(2S)-1-hydroxypropaan-2-yl]oxy}benzoëzuur - 1,4-diazabicyclo[2.2.2]octaan (2:1) |
|
2933 59 95 |
941685-39-8 |
3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1H-pyrazool-1-yl]propaannitril |
|
2933 59 95 |
941685-27-4 |
4-(1H-pyrazool-4-yl)-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine |
|
2933 59 95 |
1780-26-3 |
4,6-dichloor-2-methylpyrimidine |
|
2933 59 95 |
145783-14-8 |
4,6-dichloor-5-nitro-2-(propylsulfanyl)pyrimidine |
|
2933 59 95 |
3680-69-1 |
4-chloor-7H-pyrrolo[2,3-d]pyrimidine |
|
2933 59 95 |
61379-64-4 |
4-cyclopentylpiperazine-1-amine |
|
2933 59 95 |
55112-42-0 |
4-methylpiperazine-1-carbonylchloridehydrochloride |
|
2933 59 95 |
0-00-0 |
5-(benzylamino)-2-(3-methoxyfenyl)-7-(4-methylpiperazine-1-yl)[1,2,4]triazolo[1,5-a]chinoline-4-carbonitril-(2E)-but-2-eendioaat (2:1), hydraat |
|
2933 59 95 |
55293-96-4 |
5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine-2-carbaldehyd |
|
2933 59 95 |
179688-01-8 |
7-(benzyloxy)-6-methoxychinazolin-4(3H)-on |
|
2933 59 95 |
444731-74-2 |
N-(2-chloorpyrimidine-4-yl)-2,3-dimethyl-2H-indazool-6-amine |
|
2933 59 95 |
0-00-0 |
N-(5-fluor-3-methyl-1H-indool-1-yl)-4-methyl-2-(pyridine-2-yl)pyrimidine-5-carboxamide |
|
2933 79 00 |
586414-48-4 |
(-)-3-{3-broom-4-[(2,4-difluorbenzyl)oxy]-6-methyl-2-oxopyridine-1(2H)-yl}-N,4-dimethylbenzamide |
|
2933 79 00 |
425663-71-4 |
(1S)-1-amino-3-methyl-1,3,4,5-tetrahydro-2H-3-benzazepine-2-onhydrochloride |
|
2933 79 00 |
813452-14-1 |
(4S)-1-[(2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isochinoline-3-yl]-4-(fluormethyl)pyrrolidine-2-ondihydrochloride |
|
2933 79 00 |
5162-90-3 |
3-(2-oxo-1,2-dihydrochinoline-4-yl)alanine |
|
2933 79 00 |
536760-29-9 |
3-chloor-1-(4-nitrofenyl)-5,6-dihydropyridine-2(1H)-on |
|
2933 79 00 |
4876-10-2 |
4-(broommthyl)chinoline-2(1H)-on |
|
2933 79 00 |
5057-12-5 |
4,6,7,8-tetrahydrochinoline-2,5(1H,3H)-dion |
|
2933 79 00 |
54197-66-9 |
6-hydroxy-3,4-dihydrochinoline-2(1H)-on |
|
2933 79 00 |
22246-18-0 |
7-hydroxy-3,4-dihydrochinolin-2(1H)-on |
|
2933 79 00 |
536759-91-8 |
ethyl-1-(4-methoxyfenyl)-6-(4-nitrofenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylaat |
|
2933 79 00 |
503614-91-3 |
ethyl-1-(4-methoxyfenyl)-7-oxo-6-[4-(2-oxopiperidine-1-yl)fenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylaat |
|
2933 79 00 |
586379-61-5 |
methyl-3-(4-hydroxy-6-methyl-2-oxopyridine-1(2H)-yl)-4-methylbenzoaat |
|
2933 99 80 |
709031-45-8 |
(1S,3S,5S)-2-azabicyclo[3.1.0]hexaan-3-carboxamidemethaansulfonaat |
|
2933 99 80 |
649735-46-6 |
(2R)-1-({4-[(4-fluor-2-methyl-1H-indool-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-yl}oxy)propaan-2-ol |
|
2933 99 80 |
51077-14-6 |
(2S)-1-(tert-butoxycarbonyl)azetidine-2-carbonzuur |
|
2933 99 80 |
631916-97-7 |
(2S)-N-{4-[(Z)-amino(methoxyimino)methyl]benzyl}-1-{(2R)-2-[3-chloor-5-(difluormethoxy)fenyl]-2-hydroxyethanoyl}azetidine-2-carboxamide - benzeensulfonzuur (1:1) |
|
2933 99 80 |
80875-98-5 |
(2S,3aS,7aS)-octahydro-1H-indool-2-carbonzuur |
|
2933 99 80 |
948846-40-0 |
(2S,3S)-2,3-bis[(fenylcarbonyl)oxy]butaandizuur - ethyl-(3aR,6aR)-hexahydropyrrolo[3,4-b]pyrrool-5(1H)-carboxylaat (1:1) |
|
2933 99 80 |
1000164-36-2 |
(5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S)-5-(3-amino-3-oxopropyl)-20-benzyl-23-[(2S)-butaan-2-yl]-14,38-bis{4-[(tert-butoxycarbonyl)amino]butyl}-29-{[1-(tert-butoxycarbonyl)-1H-indool-3-yl]methyl}-17-(3-tert-butoxy-3-oxopropyl)-1-(1H-fluoreen-9-yl)-8,11,26,41,41-pentamethyl-32-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-35-(propaan-2-yl)-2-oxa-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaazadotetracontaan-42-zuur |
|
2933 99 80 |
22162-51-2 |
1-(2-nitrobenzyl)-1H-pyrrool-2-carbaldehyd |
|
2933 99 80 |
35681-40-4 |
1-(propaan-2-yl)-1,3-dihydro-2H-benzimidazool-2-on |
|
2933 99 80 |
166170-15-6 |
1-(tert-butoxycarbonyl)-2-methyl-D-proline |
|
2933 99 80 |
796967-16-3 |
1-[4-(3-amino-1H-indazool-4-yl)fenyl]-3-(2-fluor-5-methylfenyl)ureum |
|
2933 99 80 |
0-00-0 |
1-[4-(3-amino-1H-indazool-4-yl)fenyl]-3-(2-fluor-5-methylfenyl)ureumhydrochloride |
|
2933 99 80 |
444731-72-0 |
2,3-dimethyl-2H-indazool-6-amine |
|
2933 99 80 |
19686-05-6 |
2,8-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indool |
|
2933 99 80 |
912444-00-9 |
2-[(2R)-2-methylpyrrolidine-2-yl]-1H-benzimidazool-4-carboxamide |
|
2933 99 80 |
912445-36-4 |
2-[(2S)-2-methylpyrrolidine-2-yl]-1H-benzimidazool-4-carboxamidedihydrochloride |
|
2933 99 80 |
163457-23-6 |
3,3-difluorpyrrolidinehydrochloride |
|
2933 99 80 |
239463-85-5 |
3-{5-[(2R)-2-aminopropyl]-7-cyaan-2,3-dihydro-1H-indool-1-yl}propylbenzoaat-(2R,3R)-2,3-dihydroxybutaandioaat |
|
2933 99 80 |
55321-99-8 |
3-oxo-3,4-dihydropyrazine-2-carboxamide |
|
2933 99 80 |
952490-01-6 |
4-[(4-fluor-2-methyl-1H-indool-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-yl-2,2-dimethylpropanoaat |
|
2933 99 80 |
942436-93-3 |
4-amino-8-(2,5-dimethoxyfenyl)-N-propylcinnoline-3-carboxamide |
|
2933 99 80 |
942437-37-8 |
4-amino-8-(2-fluor-6-methoxyfenyl)-N-propylcinnoline-3-carboxamide |
|
2933 99 80 |
288385-88-6 |
4-fluor-2-methyl-1H-indool-5-ol |
|
2933 99 80 |
503293-47-8 |
5-(2-chloor-6-fluorfenyl)-2H-tetrazool |
|
2933 99 80 |
73963-42-5 |
5-(4-chloorbutyl)-1-cyclohexyl-1H-tetrazool |
|
2933 99 80 |
606143-52-6 |
5-[(4-broom-2-chloorfenyl)amino]-4-fluor-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazool-6-carboxamide |
|
2933 99 80 |
0-00-0 |
5-fluor-1-(3-fluorbenzyl)-N-(1H-indool-5-yl)-1H-indool-2-carboxamide |
|
2933 99 80 |
872206-47-8 |
5-methyl-4-oxo-1,4-dihydropyrrolo[2,1-f][1,2,4]triazine-6-yl 2,2-dimethylpropanoaat |
|
2933 99 80 |
259793-88-9 |
6-broom-3-oxo-3,4-dihydropyrazine-2-carboxamide |
|
2933 99 80 |
1137606-74-6 |
6-fluor-3-oxo-3,4-dihydropyrazine-2-carbonitril - N-cyclohexylcyclohexaanamine (1:1) |
|
2933 99 80 |
261953-36-0 |
6-jood-1H-indazool |
|
2933 99 80 |
80076-47-7 |
8,9-difluor-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]chinoline-2-carbonzuur |
|
2933 99 80 |
52602-39-8 |
9H-carbazool-4-ol |
|
2933 99 80 |
145641-35-6 |
benzyl-(2S,3aR,7aS)-octahydro-1H-indool-2-carboxylaathydrochloride |
|
2933 99 80 |
87269-87-2 |
benzyl-(2S,3aS,6aS)-octahydrocyclopenta[b]pyrrool-2-carboxylaathydrochloride |
|
2933 99 80 |
1012065-72-3 |
ethyl-2-amino-9,10-dimethoxy-1,6,7,11b-tetrahydro-4H-pyrido[2,1-a]isochinoline-3-carboxylaat |
|
2933 99 80 |
131707-24-9 |
ethyl-6-broom-5-hydroxy-1-methyl-2-[(fenylsulfanyl)methyl]-1H-indool-3-carboxylaat |
|
2933 99 80 |
105152-95-2 |
ethyl-7-(3-aminopyrrolidine-1-yl)-1-(2,4-difluorfenyl)-6-fluor-4-oxo-1,4-dihydro-1,8-naftyridine-3-carboxylaat |
|
2933 99 80 |
139481-44-0 |
methyl-1-[(2′-cyaanbifenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazool-7-carboxylaat |
|
2933 99 80 |
0-00-0 |
methyl-1-tert-butyl-2-hydroxy-1H-pyrrolo[2,3-b]pyridine-3-carboxylaat |
|
2933 99 80 |
21688-11-9 |
N2-[(benzyloxy)carbonyl]-L-glutaminyl-L-asparaginyl-S-benzyl-L-cysteïnyl-L-prolyl-L-leucylglycinamide |
|
2933 99 80 |
361440-67-7 |
tert-butyl-(1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexaan-2-carboxylaat |
|
2933 99 80 |
709031-38-9 |
tert-butyl (2S)-2-carbamoyl-2,3-dihydro-1H-pyrrool-1-carboxylaat |
|
2933 99 80 |
709031-43-6 |
tert-butyl-[(1S)-2-[(1S,3S,5S)-3-cyaan-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.1(3,7)] dec-1-yl)-2-oxoethyl]carbamaat |
|
2933 49 90 |
936359-25-0 |
methyl-2-((R)-3-(3-((E)-2-(7-chloorchinoline-2-yl)vinyl)fenyl)-3-(((1-(hydroxymethyl)cyclopropyl)methyl)sulfanyl)propyl)benzoaat |
|
2934 10 00 |
110130-88-6 |
(2Z)-[(acetyloxy)imino](2-amino-1,3-thiazool-4-yl)ethaanzuur |
|
2934 10 00 |
68672-66-2 |
(2Z)-{[(1-tert-butoxy-2-methyl-1-oxopropaan-2-yl)oxy]imino}[2-(tritylamino)-1,3-thiazool-4-yl]ethaanzuur |
|
2934 10 00 |
291536-35-1 |
(5Z)-5-(4-fluorbenzylideen)-1,3-thiazolidine-2,4-dion |
|
2934 10 00 |
302964-24-5 |
2-amino-N-(2-chloor-6-methylfenyl)-1,3-thiazool-5-carboxamide |
|
2934 10 00 |
866920-24-3 |
3-[2-chloor-4-({4-methyl-2-[4-(trifluormethyl)fenyl]-1,3-thiazool-5-yl}methoxy)fenyl]-1,2,4-oxadiazool-5(4H)-on |
|
2934 10 00 |
752253-39-7 |
4-(2-chloor-4-methoxy-5-methylfenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluor-4-methylfenyl)ethyl]-5-methyl-N-(prop-2-yn-1-yl)-1,3-thiazool-2-amine |
|
2934 10 00 |
914361-45-8 |
L-lysine - {[(2R,3R)-3-[4-(4-cyaanfenyl)-1,3-thiazool-2-yl]-2-(2,4-difluorfenyl)-1-(1H-1,2,4-triazool-1-yl)butaan-2-yl]oxy}methyldihydrogeenfosfaat - ethanol (1:1:1) |
|
2934 10 00 |
302964-08-5 |
N-(2-chloor-6-methylfenyl)-2-[(6-chloor-2-methylpyrimidine-4-yl)amino]-1,3-thiazool-5-carboxamide |
|
2934 10 00 |
127660-04-2 |
natrium-(2Z)-(2-amino-1,3-thiazool-4-yl)(hydroxyimino)ethanoaat |
|
2934 99 90 |
17381-54-3 |
(1-benzothiofeen-5-yl)azijnzuur |
|
2934 99 90 |
630100-90-2 |
(1R)-1,2-anhydro-4-C-{(1E,3E)-4-[(1S,2S,3E,5R,6R,9R)-5-(1-carboxylato-4-cycloheptylpiperazine-2-yl)-6,9-dihydroxy-2,6-dimethyl-11-oxooxacyclododec-3-een-1-yl]penta-1,3-dieen-1-yl}-3,5-dideoxy-1-[(2R,3S)-3-hydroxypentaan-2-yl]-D-erytropentitol |
|
2934 99 90 |
220099-91-2 |
(2R)-3′H-spiro[4-azabicyclo[2.2.2]octaan-2,2′-furo[2,3-b]pyridine] |
|
2934 99 90 |
220100-81-2 |
(2R)-3′H-spiro[4-azabicyclo[2.2.2]octaan-2,2′-furo[2,3-b]pyridine]-(S,S)-2,3-dihydroxybutaandioaat |
|
2934 99 90 |
161599-46-8 |
(2R,3R,4R,5R)-2-(4-amino-5-fluor-2-oxopyrimidine-1(2H)-yl)-2-fluor-5-methyltetrahydrofuran-3,4-diyldiacetaat |
|
2934 99 90 |
690270-65-6 |
(2R,3S,4R)-5-(4-amino-2-oxopyrimidine-1(2H)-yl)-2-azido-2-{[(2-methylpropanoyl)oxy]methyl}tetrahydrofuran-3,4-diylbis(2-methylpropanoaat)hydrochloride |
|
2934 99 90 |
265121-04-8 |
(3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluormethyl)fenyl]ethoxy}-3-(2-fluorfenyl)morfoline-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazool-1-yl)fosfonzuur – 1-deoxy-1-(methylamino)-D-glucitol (1:2) |
|
2934 99 90 |
163680-80-6 |
(3S)-10-[1-(acetylamino)cyclopropyl]-9-fluor-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]chinoline-6-carbonzuur |
|
2934 99 90 |
132335-46-7 |
(3S)-N,N-dimethyl-3-(naftaleen-1-yloxy)-3-(thiofeen-2-yl)propaan-1-amine |
|
2934 99 90 |
133413-70-4 |
(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-4,10,12,16,22,24-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosaan-2,5,8,11,14,17,20,23-octaon |
|
2934 99 90 |
503068-36-8 |
(5R)-3-(6-{2-[(2,6-dichloorbenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxine-6-yl)-1,3-oxazolidine-2-on |
|
2934 99 90 |
452339-73-0 |
(5R)-5-(2,2-dimethyl-4H-1,3-benzodioxine-6-yl)-1,3-oxazolidin-2-on |
|
2934 99 90 |
877130-28-4 |
(6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridine-4-yl)ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine-2-yl)methyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-on |
|
2934 99 90 |
132335-44-5 |
(S)-3-(dimethylamino)-1-(thiofeen-2-yl)propaan-1-ol |
|
2934 99 90 |
812647-80-6 |
{(2R,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidine-1(2H)-yl)-3,4-bis[(fenylcarbonyl)oxy]tetrahydrofuran-2-yl}methyl-3-chloorbenzoaat |
|
2934 99 90 |
00-00-0 |
1-(1-{4-[2-(4-fluorfenyl)-1,3-dioxolaan-2-yl]butyl}-1,2,3,6-tetrahydropyridine-4-yl)-1,3-dihydro-2H-benzimidazool-2-on |
|
2934 99 90 |
1029716-44-6 |
1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolaan-2-yl)-1H-pyrazool |
|
2934 99 90 |
165172-60-1 |
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dion - 1-methylpyrrolidine-2-on (1:1) |
|
2934 99 90 |
519187-97-4 |
1-[3-(2-benzo[b]thiofeen-5-ylethoxy)propyl]-3-azetidinol - (2Z)-2-buteendioaat (1:1) |
|
2934 99 90 |
127000-90-2 |
1-{[(2R,3S)-2-(2,4-difluorfenyl)-3-methyloxiraan-2-yl]methyl}-1H-1,2,4-triazool |
|
2934 99 90 |
710281-33-7 |
2-({[(1R,3S)-3-{[2-(3-methoxyfenyl)-5-methyl-1,3-oxazool-4-yl]methoxy}cyclohexyl]oxy}methyl)-6-methylbenzoëzuur |
|
2934 99 90 |
96803-30-4 |
2-(1-benzothiofeen-5-yl)ethanol |
|
2934 99 90 |
913695-00-8 |
2-[({4-[(2,2-dimethyl-1,3-dioxaan-5-yl)methoxy]-3,5-dimethylpyridine-2-yl}methyl)sulfinyl]-1H-benzimidazool, natriumzout (1:1) |
|
2934 99 90 |
376608-74-1 |
2-{[(3aR,4S,6R,6aS)-6-{[5-amino-6-chloor-2-(propylsulfanyl)pyrimidine-4-yl]amino}-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxool-4-yl]oxy}ethanol |
|
2934 99 90 |
474554-48-8 |
2-broom-1-[3-tert-butyl-4-methoxy-5-(morfoline-4-yl)fenyl]ethanon |
|
2934 99 90 |
530141-72-1 |
3-(5-{[4-(cyclopentyloxy)-2-hydroxyfenyl]carbonyl}-2-[(3-hydroxy-1,2-benzoxazool-6-yl)methoxy]fenyl)propaanzuur |
|
2934 99 90 |
519188-55-7 |
3-[2-(1-benzothiofeen-5-yl)ethoxy]-1-(3-hydroxyazetidine-1-yl)propaan-1-on |
|
2934 99 90 |
519188-42-2 |
3-[2-(1-benzothiofeen-5-yl)ethoxy]propionzuur |
|
2934 99 90 |
753015-42-8 |
3-{(E)-2-[(3R)-pyrrolidine-3-yl]ethenyl}-5-(tetrahydro-2H-pyran-4-yloxy)pyridine |
|
2934 99 90 |
26638-53-9 |
3-chloor-6-methyldibenzo[c,f][1,2]thiazepine-11(6H)-on-5,5-dioxide |
|
2934 99 90 |
499785-81-8 |
3-oxo-4-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide |
|
2934 99 90 |
356782-84-8 |
3-oxo-4-(β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide |
|
2934 99 90 |
6504-57-0 |
4-[3-fenyl-3-hydroxy-3-(thiofeen-2-yl)propyl]-4-methylmorfoline-4-iummethylsulfaat |
|
2934 99 90 |
871484-32-1 |
4-[4-({3-[(4-deoxy-4-fluor-β-D-glucopyranosyl)oxy]-5-(propaan-2-yl)-1H-pyrazool-4-yl}methyl)fenyl]-N-[1,3-dihydroxy-2-(hydroxymethyl)propaan-2-yl]butaanamide |
|
2934 99 90 |
166964-09-6 |
4-chloor-3-methyl-1,2-oxazool-5-amine |
|
2934 99 90 |
655233-39-3 |
4-nitrobenzyl-(6R,7R)-7-amino-8-oxo-3-[(2S)-tetrahydrofuran-2-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-een-2-carboxylaathydrochloride |
|
2920 90 85 |
89729-09-9 |
5,7-dioxa-6-thiaspiro[2.5]octaan-6-oxide |
|
2934 99 90 |
388082-75-5 |
5-[4-[[3-chloor-4-[(3-fluorfenyl)methoxy]fenyl]amino]-6-chinazolinyl]-2-furancarboxaldehyd-4-methylbenzeensulfonaat (1:1) |
|
2934 99 90 |
4923-87-9 |
5-broom-1-benzothiofeen |
|
2934 99 90 |
947408-95-9 |
6-(broommethyl)-2-trifenylmethyl-1,2-benzisoxazool-3(2H)-on |
|
2934 99 90 |
947408-94-8 |
6-methyl-2-trityl-1,2-benzoxazool-3(2H)-on |
|
2934 99 90 |
67978-05-6 |
difenylmethyl-(2R)-3-methyl-2-[(1R,5S)-3-(4-methylfenyl)-7-oxo-4-oxa-2,6-diazabicyclo[3.2.0]hept-2-een-6-yl]but-3-enoaat |
|
2934 99 90 |
1001859-46-6 |
DNA (synthetische plasmidevector pCOR die een fusie-eiwit tot expressie brengt van een signaalpeptide van humaan interferon bèta met het deel 21-154 van humane zure fibroblastgroeifactor) |
|
2934 99 90 |
665058-78-6 |
DNA, d(T-sp-C-G-sp-T-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G-sp-A-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-Gsp-T-sp-C-G-sp-T-sp-T) |
|
2934 99 90 |
923591-06-4 |
methyl-(5R,7S,10S)-10-tert-butyl-15,15-dimethyl-3,9,12-trioxo-6,7,9,10,11,12,14,15,16,17,18,19-dodecahydro-1H,5H-2,23:5,8-dimethano-4,13,2,8,11-benzodioxatriazacyclohenicosine-7(3H)-carboxylaat |
|
2934 99 90 |
59337-92-7 |
methyl-3-(chloorsulfonyl)thiofeen-2-carboxylaat |
|
2934 99 90 |
947409-01-0 |
methyl-3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2-trifenylmethyl-1,2-benzisoxazool-3(2H)-on-6-yl)methoxy]fenyl]propionaat |
|
2934 99 90 |
85006-31-1 |
methyl-3-amino-4-methylthiofeen-2-carboxylaat |
|
2934 99 90 |
893428-72-3 |
N-(5-chloor-1,3-benzodioxool-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-chinazolinamine – (2E)-2-buteendioaat (1:2) |
|
2934 99 90 |
390800-88-1 |
N,N′,N′′-(boroxine-2,4,6-triyltris{[(1S)-3-methylbutaan-1,1-diyl]imino[(2S)- 3-fenyl-1-oxopropaan-1,2-diyl]})tripyrazine-2-carboxamide |
|
2934 99 90 |
112913-94-7 |
N-{[4-(4-fluorbenzyl)morfoline-2-yl]methyl}aceetamide |
|
2934 99 90 |
120788-03-6 |
S-[(1R,3S)-1-oxidotetrahydrothiofeen-3-yl] ethaanthioaat |
|
2935 00 90 |
1198178-65-2 |
(1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethylcyclopropaanaminium-4-methylbenzeensulfonaat |
|
2935 00 90 |
39570-96-2 |
(2R)-3-(benzylsulfanyl)-N-[(2S)-1-{[(2S,3S)-1-hydrazinyl-3-methyl-1-oxopentaan-2-yl]amino}-3-(4-hydroxyfenyl)-1-oxopropaan-2-yl]-2-{[(4-methylfenyl)sulfonyl]amino}propaanamide |
|
2935 00 90 |
24310-36-9 |
1-[(4-methylfenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepine-5-on |
|
2935 00 90 |
0-00-0 |
2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidine-2-yl]ethyl}-1,2,3,4-tetrahydroisochinoline-7-sulfonamidedi[(2E)-but-2-eendioaat]-hydraat |
|
2935 00 90 |
941690-55-7 |
2-fenyl-N-[(1S)-1-fenylpropyl]-3-[(methylsulfonyl)amino]chinoline-4-carboxamide |
|
2935 00 90 |
6973-09-7 |
5-amino-2-methylbenzeensulfonamide |
|
2935 00 90 |
193686-76-9 |
7-chloor-1-[(4-methylfenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepine-5-on |
|
2935 00 90 |
123664-84-6 |
N-(5-methoxy-2-fenoxyfenyl)methaansulfonamide |
|
2935 00 90 |
149457-03-4 |
N-[2-fenoxy-4-(N-formylglycyl)-5-hydroxyfenyl]methaansulfonamide |
|
2935 00 90 |
149456-98-4 |
N-[2-fenoxy-4-(N-formylglycyl)-5-methoxyfenyl]methaansulfonamide |
|
2935 00 90 |
141450-48-8 |
N-{2-[(4-hydroxyfenyl)amino]pyridine-3-yl}-4-methoxybenzeensulfonamidehydrochloride |
|
2935 00 90 |
289042-10-0 |
N-{5-[(difenylfosforyl)methyl]-4-(4-fluorfenyl)-6-(propaan-2-yl)pyrimidine-2-yl}-N-methylmethaansulfonamide |
|
2939 99 00 |
7689-03-4 |
(4S)-4-ethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]chinoline-3,14(4H,12H)-dion |
|
2939 99 00 |
477-29-2 |
colchicoside |
|
2940 00 00 |
604-69-3 |
1,2,3,4,6-penta-O-acetyl-β-D-glucopyranose |
|
2940 00 00 |
647834-15-9 |
2-(4-methoxybenzyl)thiofeen-3-yl-β-D-glucopyranoside |
|
2941 90 00 |
76610-92-9 |
(6R,7R)-7-({N-[(4-ethyl-2,3-dioxopiperazine-1-yl)carbonyl]-D-treonyl}amino)-3-{[(1-methyl-1H-tetrazool-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-een-2-carbonzuur |
|
3907 20 99 |
913976-27-9 |
poly(oxy-1,2-ethaandiyl), α-hydro-ω-methoxy, diëster met 21N6, 21′N6-[[(N2, N6-dicarboxy-L-lysyl-β-alanyl)imino]bis(1-oxo-2,1-ethaandiyl)]bis[N-acetylglycyl-L-leucyl-L-tyrosyl-L-alanyl-L-cysteïnyl-L-histidyl-L-methionylglycyl-L-prolyl-L-isoleucyl-L-treonyl-3-(1-naftalenyl)-L-alanyl-L-valyl-L-cysteïnyl-L-glutaminyl-L-prolyl-L-leucyl-L-arginyl-N-methylglycyl-L-lysinamide], cyclisch (6→15), (6′→15′) bis(disulfide) |
BIJLAGE IV
Lijst van farmaceutische tussenproducten, dat wil zeggen verbindingen die bij de vervaardiging van farmaceutische eindproducten worden gebruikt, die moeten worden geschrapt van de lijst van producten waarop geen rechten van toepassing zijn van bijlage 6 bij bijlage I bij Verordening (EEG) nr. 2658/87 omdat zij zijn overgebracht naar de lijst van producten waarop geen rechten van toepassing zijn in bijlage 3 bij bijlage I bij Verordening (EEG) nr. 2658/87
|
GN code |
CAS-nummer |
Naam |
|
2915 39 00 2937 29 00 |
7753-60-8 |
17-alfa-hydroxy-3,20-dioxopregn-4,9(11)-dieen-21-ylacetaat zie anecortave (INN) |
|
2920 90 85 |
163133-43-5 |
4-(nitrooxy)butyl-(2S)-2-(6-methoxy-2-naftyl)propanoaat zie naproxcinod (INN) |
|
2924 29 98 |
194085-75-1 |
2-(2-chloorfenyl)-2-hydroxyethylcarbamaat zie carisbamaat (INN) |
|
2933 39 99 |
103129-82-4 |
3-ethyl-5-methyl-2-[(2-aminoethoxy)methyl]-4-(2-chloorfenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylaat zie levamlodipine (INN) |
|
2933 39 99 |
319460-85-0 |
N-methyl-2-{[3-((E)-2-pyridine-2-ylvinyl)-1H-indazool-6-yl]sulfanyl}benzamide zie axitinib (INN) |
|
2934 10 00 |
302962-49-8 |
N-(2-chloor-6-methylfenyl)-2-({6-[4-(2-hydroxyethyl) piperazine-1-yl]-2-methylpyrimidine-4-yl}amino)thiazool-5-carboxamide zie dasatinib (INN) |
|
2934 99 90 |
143491-57-0 |
(2R,5S)-4-amino-5-fluor-1-[2-(hydroxymethyl)-1,3-oxathiolaan-5-yl]pyrimidine-2(1H)-on zie emtricitabine (INN) |
|
2934 99 90 |
98819-76-2 |
(2S)-2-[(S)-(2-ethoxyfenoxy)fenylmethyl]morfoline zie esreboxetine (INN) |
|
2934 99 90 |
475479-34-6 |
(2S)-2-methoxy-3-{4-[2-(2-fenyl-5-methyl-1,3-oxazool- 4-yl)ethoxy]-1-benzothiofeen-7-yl}propaanzuur zie aleglitazar (INN) |
|
2934 99 90 |
377727-87-2 |
2-(2-furyl)-7-(2-{4-[4-(2-methoxyethoxy)fenyl]piperazine- 1-yl}ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[2,3-c]pyrimidine-5-amine zie preladenant (INN) |
|
2934 99 90 |
189003-92-7 |
2-{7-fluor-2-oxo-4-[2-(4-thieno[3,2-c]pyridine-4-ylpiperazine- 1-yl)ethyl]chinoline-1(2H)-yl}aceetamide zie trelanserin (INN) |
|
2934 99 90 |
134379-77-4 |
4-amino-5-fluor-1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidine-2(1H)-on zie dexelvucitabine (INN) |
|
2934 99 90 |
518048-05-0 |
kalium-4-[N-(2-fluorbenzyl)carbamoyl]-1-methyl-2-[1-methyl-1-(5-methyl-1,3,4-oxadiazool-2-carboxamido)ethyl]-6-oxo-1,6-dihydropyrimidine-5-olaat zie raltegravir (INN) |
|
2935 00 90 |
170569-88-7 |
4-[5-(4-fluorfenyl)-3-(trifluormethyl)pyrazool-1-yl]benzeen-1-sulfonamide zie mavacoxib (INN) |
|
2935 00 90 |
186497-07-4 |
N-(3-methoxy-5-methylpyrazine-2-yl)-2-[4-(1,3,4-oxadiazool-2-yl)fenyl]pyridine-3-sulfonamide zie zibotentan (INN) |
